Low mortality of hospitalised patients with COVID-19 in a tertiary Danish hospital setting
Objectives: We aimed to describe clinical characteristics and outcomes of admitted COVID-19 patients in a Danish hospital setting where an early active government intervention was taken. Methods: Prospective cohort study including all admitted patients to the COVID-19 unit at Odense University Hospital from March 10 to April 21, 2020. Patients were assessed by a multidisciplinary team at admission. Outcome parameters were development of acute respiratory distress syndrome (ARDS), intensive care unit (ICU) admission, death and admission time. Results: We included 83 patients (median age 62 years, 62.7% male). At hospitalization, 31.3% needed oxygen supplementation and the median National Early Warning Score was four. Median admission time was 7 days (Interquartile ranges (IQR) 3-12). In total, ARDS was diagnosed in 33.7% (28/83) of the patients corresponding to an incidence rate of 7.1 per 100 person days (95% CI: 4.1-10.2). Overall 13 patients (15.7%) were transferred to the ICU of whom 11 (84.6%) received corticosteroids.. No patients died while admitted to the ICU. Four patients (4.8%) died during admission. Conclusion: Despite similar patient characteristics compared to those reported by others, we found a low overall mortality of < 5%..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:102 |
---|---|
Enthalten in: |
International Journal of Infectious Diseases - 102(2021), Seite 212-219 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Lone Wulff Madsen [VerfasserIn] |
---|
Links: |
doi.org [kostenfrei] |
---|
Themen: |
COVID-19 |
---|
doi: |
10.1016/j.ijid.2020.10.018 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
DOAJ059405414 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ059405414 | ||
003 | DE-627 | ||
005 | 20230502133013.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230228s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.ijid.2020.10.018 |2 doi | |
035 | |a (DE-627)DOAJ059405414 | ||
035 | |a (DE-599)DOAJ0e4243ae00fc47a19296c3cb8c26db20 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
050 | 0 | |a RC109-216 | |
100 | 0 | |a Lone Wulff Madsen |e verfasserin |4 aut | |
245 | 1 | 0 | |a Low mortality of hospitalised patients with COVID-19 in a tertiary Danish hospital setting |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Objectives: We aimed to describe clinical characteristics and outcomes of admitted COVID-19 patients in a Danish hospital setting where an early active government intervention was taken. Methods: Prospective cohort study including all admitted patients to the COVID-19 unit at Odense University Hospital from March 10 to April 21, 2020. Patients were assessed by a multidisciplinary team at admission. Outcome parameters were development of acute respiratory distress syndrome (ARDS), intensive care unit (ICU) admission, death and admission time. Results: We included 83 patients (median age 62 years, 62.7% male). At hospitalization, 31.3% needed oxygen supplementation and the median National Early Warning Score was four. Median admission time was 7 days (Interquartile ranges (IQR) 3-12). In total, ARDS was diagnosed in 33.7% (28/83) of the patients corresponding to an incidence rate of 7.1 per 100 person days (95% CI: 4.1-10.2). Overall 13 patients (15.7%) were transferred to the ICU of whom 11 (84.6%) received corticosteroids.. No patients died while admitted to the ICU. Four patients (4.8%) died during admission. Conclusion: Despite similar patient characteristics compared to those reported by others, we found a low overall mortality of < 5%. | ||
650 | 4 | |a COVID-19 | |
650 | 4 | |a SARS-CoV-2 | |
650 | 4 | |a clinical | |
650 | 4 | |a mortality | |
650 | 4 | |a demography | |
650 | 4 | |a epidemiology | |
653 | 0 | |a Infectious and parasitic diseases | |
700 | 0 | |a Susan Olaf Lindvig |e verfasserin |4 aut | |
700 | 0 | |a Line Dahlerup Rasmussen |e verfasserin |4 aut | |
700 | 0 | |a Fredrikke Christie Knudtzen |e verfasserin |4 aut | |
700 | 0 | |a Christian B. Laursen |e verfasserin |4 aut | |
700 | 0 | |a Anne Øvrehus |e verfasserin |4 aut | |
700 | 0 | |a Stig Lønberg Nielsen |e verfasserin |4 aut | |
700 | 0 | |a Isik Somuncu Johansen |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t International Journal of Infectious Diseases |d Elsevier, 2015 |g 102(2021), Seite 212-219 |w (DE-627)DOAJ000043923 |x 18783511 |7 nnns |
773 | 1 | 8 | |g volume:102 |g year:2021 |g pages:212-219 |
856 | 4 | 0 | |u https://doi.org/10.1016/j.ijid.2020.10.018 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/0e4243ae00fc47a19296c3cb8c26db20 |z kostenfrei |
856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S1201971220322219 |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/1201-9712 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_DOAJ | ||
912 | |a SSG-OLC-PHA | ||
951 | |a AR | ||
952 | |d 102 |j 2021 |h 212-219 |